Company Filing History:
Years Active: 2006-2012
Title: Innovator Spotlight: Monika Ühlein
Introduction
Monika Ühlein is a prominent inventor based in Berlin, Germany, known for her contributions to medical diagnostics and therapeutic interventions. With a total of three patents to her name, Ühlein's work addresses critical challenges in the fields of inflammatory diseases and sepsis.
Latest Patents
Among her latest patents, one focuses on the use of calcineurin B homologous protein (CHP) from body fluids or tissues as a marker peptide for diagnosing, prognosing, and monitoring the progress of inflammations and infections. This innovative approach not only aids in the accurate diagnosis of sepsis-type inflammatory diseases but also serves as a potential target for therapeutically influencing disease progression.
Another significant patent involves the use of aldose-1-epimerase (mutarotase) from body fluids or tissues in both human and veterinary medicine. This patent elucidates its role as a marker peptide and a therapeutic target for managing inflammatory diseases and sepsis, offering promising advancements in disease treatment and management.
Career Highlights
Monika Ühlein is affiliated with B.R.A.H.M.S Aktiengesellschaft, where she continues her pioneering research in medical diagnostics. Her career is marked by a dedication to innovation and the development of effective solutions for challenging health issues.
Collaborations
Throughout her career, Ühlein has collaborated with notable colleagues such as Andreas Bergmann and Joachim Struck. Together, they contribute to advancing the understanding and treatment of inflammatory conditions and sepsis, furthering the impact of their collective research efforts.
Conclusion
Monika Ühlein’s contributions to the field of medical science through her patents play a vital role in enhancing diagnostic techniques and therapeutic options for inflammatory diseases and sepsis. Her ongoing work continues to inspire advancements in healthcare, affirming her status as a significant figure in innovative medical research.